longtext: 7vjt-pdb

content
HEADER    TRANSFERASE                             28-SEP-21   7VJT
TITLE     CRYSTAL STRUCTURE OF MTB PKS13-TE IN COMPLEX WITH INHIBITOR COUMESTAN
TITLE    2 DERIVATIVE 8
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: POLYKETIDE SYNTHASE PKS13 (TERMINATION POLYKETIDE
COMPND   3 SYNTHASE);
COMPND   4 CHAIN: A, B;
COMPND   5 EC: 2.7.7.-;
COMPND   6 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS;
SOURCE   3 ORGANISM_TAXID: 1773;
SOURCE   4 GENE: PKS, ERS007688_02231;
SOURCE   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS    TUBERCULOSIS, MYCOBACTERIUM TUBERCULOSIS, ANTIBIOTIC, TRANSFERASE
EXPDTA    X-RAY DIFFRACTION
AUTHOR    W.ZHANG,S.S.WANG,L.F.YU
REVDAT   4   29-NOV-23 7VJT    1       REMARK
REVDAT   3   26-OCT-22 7VJT    1       JRNL
REVDAT   2   19-OCT-22 7VJT    1       JRNL
REVDAT   1   28-SEP-22 7VJT    0
JRNL        AUTH   W.ZHANG,S.LUN,S.S.WANG,Y.P.CAI,F.YANG,J.TANG,W.R.BISHAI,
JRNL        AUTH 2 L.F.YU
JRNL        TITL   STRUCTURE-BASED OPTIMIZATION OF COUMESTAN DERIVATIVES AS
JRNL        TITL 2 POLYKETIDE SYNTHASE 13-THIOESTERASE(PKS13-TE) INHIBITORS
JRNL        TITL 3 WITH IMPROVED HERG PROFILES FOR MYCOBACTERIUM TUBERCULOSIS
JRNL        TITL 4 TREATMENT.
JRNL        REF    J.MED.CHEM.                   V.  65 13240 2022
JRNL        REFN                   ISSN 0022-2623
JRNL        PMID   36174223
JRNL        DOI    10.1021/ACS.JMEDCHEM.2C01064
REMARK   2
REMARK   2 RESOLUTION.    1.94 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : REFMAC 7.1
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 81.91
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 1.340
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.0
REMARK   3   NUMBER OF REFLECTIONS             : 39170
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : NULL
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.187
REMARK   3   R VALUE            (WORKING SET) : 0.185
REMARK   3   FREE R VALUE                     : 0.224
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.040
REMARK   3   FREE R VALUE TEST SET COUNT      : 1974
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 4264
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 54
REMARK   3   SOLVENT ATOMS            : 196
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : NULL
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 22.43
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : NULL
REMARK   3    B22 (A**2) : NULL
REMARK   3    B33 (A**2) : NULL
REMARK   3    B12 (A**2) : NULL
REMARK   3    B13 (A**2) : NULL
REMARK   3    B23 (A**2) : NULL
REMARK   3
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.
REMARK   3   ESU BASED ON R VALUE                            (A): NULL
REMARK   3   ESU BASED ON FREE R VALUE                       (A): NULL
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.220
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.
REMARK   3   DISTANCE RESTRAINTS.                    RMS    SIGMA
REMARK   3    BOND LENGTH                     (A) : NULL  ; NULL
REMARK   3    ANGLE DISTANCE                  (A) : NULL  ; NULL
REMARK   3    INTRAPLANAR 1-4 DISTANCE        (A) : NULL  ; NULL
REMARK   3    H-BOND OR METAL COORDINATION    (A) : NULL  ; NULL
REMARK   3
REMARK   3   PLANE RESTRAINT                  (A) : NULL  ; NULL
REMARK   3   CHIRAL-CENTER RESTRAINT       (A**3) : NULL  ; NULL
REMARK   3
REMARK   3   NON-BONDED CONTACT RESTRAINTS.
REMARK   3    SINGLE TORSION                  (A) : NULL  ; NULL
REMARK   3    MULTIPLE TORSION                (A) : NULL  ; NULL
REMARK   3    H-BOND (X...Y)                  (A) : NULL  ; NULL
REMARK   3    H-BOND (X-H...Y)                (A) : NULL  ; NULL
REMARK   3
REMARK   3   CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK   3    SPECIFIED                 (DEGREES) : NULL  ; NULL
REMARK   3    PLANAR                    (DEGREES) : NULL  ; NULL
REMARK   3    STAGGERED                 (DEGREES) : NULL  ; NULL
REMARK   3    TRANSVERSE                (DEGREES) : NULL  ; NULL
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: NULL
REMARK   4
REMARK   4 7VJT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-OCT-21.
REMARK 100 THE DEPOSITION ID IS D_1300024820.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 29-NOV-20
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : 4.6
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : SSRF
REMARK 200  BEAMLINE                       : BL17U1
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9793
REMARK 200  MONOCHROMATOR                  : ADSC QUANTUM 315R
REMARK 200  OPTICS                         : NULL
REMARK 200
REMARK 200  DETECTOR TYPE                  : CCD
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315R
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200  DATA SCALING SOFTWARE          : HKL-2000
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 39267
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.940
REMARK 200  RESOLUTION RANGE LOW       (A) : 81.910
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.3
REMARK 200  DATA REDUNDANCY                : 6.000
REMARK 200  R MERGE                    (I) : 0.12100
REMARK 200  R SYM                      (I) : NULL
REMARK 200   FOR THE DATA SET  : 10.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.98
REMARK 200  COMPLETENESS FOR SHELL     (%) : NULL
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL
REMARK 200  R MERGE FOR SHELL          (I) : 0.38500
REMARK 200  R SYM FOR SHELL            (I) : NULL
REMARK 200   FOR SHELL         : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: REFMAC
REMARK 200 STARTING MODEL: 5V3Y
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 40.05
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM AMMONIUM ACETATE, 100 MM SODIUM
REMARK 280  ACETATE TRIHYDRATE (PH 4.6), AND 30% (W/V) POLYETHYLENE GLYCOL
REMARK 280  4000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291.2K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X,Y,-Z
REMARK 290       3555   X+1/2,Y+1/2,Z+1/2
REMARK 290       4555   -X+1/2,Y+1/2,-Z+1/2
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       27.99965
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       19.21500
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000       79.04314
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       27.99965
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       19.21500
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000       79.04314
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     SER A  1443
REMARK 465     ASN A  1444
REMARK 465     ILE A  1445
REMARK 465     GLY A  1446
REMARK 465     SER A  1447
REMARK 465     GLY A  1448
REMARK 465     GLY A  1449
REMARK 465     SER A  1728
REMARK 465     GLU A  1729
REMARK 465     VAL A  1730
REMARK 465     GLY A  1731
REMARK 465     LYS A  1732
REMARK 465     GLN A  1733
REMARK 465     SER B  1443
REMARK 465     ASN B  1444
REMARK 465     ILE B  1445
REMARK 465     GLY B  1446
REMARK 465     SER B  1447
REMARK 465     GLY B  1448
REMARK 465     GLY B  1449
REMARK 465     SER B  1450
REMARK 465     GLN B  1620
REMARK 465     SER B  1621
REMARK 465     GLY B  1622
REMARK 465     VAL B  1623
REMARK 465     GLN B  1624
REMARK 465     SER B  1728
REMARK 465     GLU B  1729
REMARK 465     VAL B  1730
REMARK 465     GLY B  1731
REMARK 465     LYS B  1732
REMARK 465     GLN B  1733
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470   M RES CSSEQI  ATOMS
REMARK 470     SER A1450    OG
REMARK 470     GLN A1451    CG   CD   OE1  NE2
REMARK 470     GLU A1464    CG   CD   OE1  OE2
REMARK 470     GLN A1570    CG   CD   OE1  NE2
REMARK 470     LYS A1572    NZ
REMARK 470     LYS A1588    CD   CE   NZ
REMARK 470     GLU A1604    CG   CD   OE1  OE2
REMARK 470     ARG A1612    CG   CD   NE   CZ   NH1  NH2
REMARK 470     GLU A1685    CG   CD   OE1  OE2
REMARK 470     THR A1727    OG1  CG2
REMARK 470     GLU B1464    CG   CD   OE1  OE2
REMARK 470     GLU B1608    CG   CD   OE1  OE2
REMARK 470     ARG B1612    CG   CD   NE   CZ   NH1  NH2
REMARK 470     LEU B1615    CG   CD1  CD2
REMARK 470     ASP B1616    CG   OD1  OD2
REMARK 470     ILE B1625    CG1  CG2  CD1
REMARK 470     GLU B1713    CD   OE1  OE2
REMARK 470     THR B1727    OG1  CG2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3
REMARK 500    ARG A1578   NE  -  CZ  -  NH1 ANGL. DEV. =   3.1 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    SER A1533     -130.53     57.53
REMARK 500    GLN A1570       77.38   -106.57
REMARK 500    SER B1533     -134.37     59.01
REMARK 500    GLN B1570       75.74   -106.49
REMARK 500
REMARK 500 REMARK: NULL
DBREF1 7VJT A 1451  1733  UNP                  A0A654TNE3_MYCTX
DBREF2 7VJT A     A0A654TNE3                        335         617
DBREF1 7VJT B 1451  1733  UNP                  A0A654TNE3_MYCTX
DBREF2 7VJT B     A0A654TNE3                        335         617
SEQADV 7VJT SER A 1443  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT ASN A 1444  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT ILE A 1445  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT GLY A 1446  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT SER A 1447  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT GLY A 1448  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT GLY A 1449  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT SER A 1450  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT SER B 1443  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT ASN B 1444  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT ILE B 1445  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT GLY B 1446  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT SER B 1447  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT GLY B 1448  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT GLY B 1449  UNP  A0A654TNE           EXPRESSION TAG
SEQADV 7VJT SER B 1450  UNP  A0A654TNE           EXPRESSION TAG
SEQRES   1 A  291  SER ASN ILE GLY SER GLY GLY SER GLN ILE ASP GLY PHE
SEQRES   2 A  291  VAL ARG THR LEU ARG ALA ARG PRO GLU ALA GLY GLY LYS
SEQRES   3 A  291  VAL PRO VAL PHE VAL PHE HIS PRO ALA GLY GLY SER THR
SEQRES   4 A  291  VAL VAL TYR GLU PRO LEU LEU GLY ARG LEU PRO ALA ASP
SEQRES   5 A  291  THR PRO MET TYR GLY PHE GLU ARG VAL GLU GLY SER ILE
SEQRES   6 A  291  GLU GLU ARG ALA GLN GLN TYR VAL PRO LYS LEU ILE GLU
SEQRES   7 A  291  MET GLN GLY ASP GLY PRO TYR VAL LEU VAL GLY TRP SER
SEQRES   8 A  291  LEU GLY GLY VAL LEU ALA TYR ALA CYS ALA ILE GLY LEU
SEQRES   9 A  291  ARG ARG LEU GLY LYS ASP VAL ARG PHE VAL GLY LEU ILE
SEQRES  10 A  291  ASP ALA VAL ARG ALA GLY GLU GLU ILE PRO GLN THR LYS
SEQRES  11 A  291  GLU GLU ILE ARG LYS ARG TRP ASP ARG TYR ALA ALA PHE
SEQRES  12 A  291  ALA GLU LYS THR PHE ASN VAL THR ILE PRO ALA ILE PRO
SEQRES  13 A  291  TYR GLU GLN LEU GLU GLU LEU ASP ASP GLU GLY GLN VAL
SEQRES  14 A  291  ARG PHE VAL LEU ASP ALA VAL SER GLN SER GLY VAL GLN
SEQRES  15 A  291  ILE PRO ALA GLY ILE ILE GLU HIS GLN ARG THR SER TYR
SEQRES  16 A  291  LEU ASP ASN ARG ALA ILE ASP THR ALA GLN ILE GLN PRO
SEQRES  17 A  291  TYR ASP GLY HIS VAL THR LEU TYR MET ALA ASP ARG TYR
SEQRES  18 A  291  HIS ASP ASP ALA ILE MET PHE GLU PRO ARG TYR ALA VAL
SEQRES  19 A  291  ARG GLN PRO ASP GLY GLY TRP GLY GLU TYR VAL SER ASP
SEQRES  20 A  291  LEU GLU VAL VAL PRO ILE GLY GLY GLU HIS ILE GLN ALA
SEQRES  21 A  291  ILE ASP GLU PRO ILE ILE ALA LYS VAL GLY GLU HIS MET
SEQRES  22 A  291  SER ARG ALA LEU GLY GLN ILE GLU ALA ASP ARG THR SER
SEQRES  23 A  291  GLU VAL GLY LYS GLN
SEQRES   1 B  291  SER ASN ILE GLY SER GLY GLY SER GLN ILE ASP GLY PHE
SEQRES   2 B  291  VAL ARG THR LEU ARG ALA ARG PRO GLU ALA GLY GLY LYS
SEQRES   3 B  291  VAL PRO VAL PHE VAL PHE HIS PRO ALA GLY GLY SER THR
SEQRES   4 B  291  VAL VAL TYR GLU PRO LEU LEU GLY ARG LEU PRO ALA ASP
SEQRES   5 B  291  THR PRO MET TYR GLY PHE GLU ARG VAL GLU GLY SER ILE
SEQRES   6 B  291  GLU GLU ARG ALA GLN GLN TYR VAL PRO LYS LEU ILE GLU
SEQRES   7 B  291  MET GLN GLY ASP GLY PRO TYR VAL LEU VAL GLY TRP SER
SEQRES   8 B  291  LEU GLY GLY VAL LEU ALA TYR ALA CYS ALA ILE GLY LEU
SEQRES   9 B  291  ARG ARG LEU GLY LYS ASP VAL ARG PHE VAL GLY LEU ILE
SEQRES  10 B  291  ASP ALA VAL ARG ALA GLY GLU GLU ILE PRO GLN THR LYS
SEQRES  11 B  291  GLU GLU ILE ARG LYS ARG TRP ASP ARG TYR ALA ALA PHE
SEQRES  12 B  291  ALA GLU LYS THR PHE ASN VAL THR ILE PRO ALA ILE PRO
SEQRES  13 B  291  TYR GLU GLN LEU GLU GLU LEU ASP ASP GLU GLY GLN VAL
SEQRES  14 B  291  ARG PHE VAL LEU ASP ALA VAL SER GLN SER GLY VAL GLN
SEQRES  15 B  291  ILE PRO ALA GLY ILE ILE GLU HIS GLN ARG THR SER TYR
SEQRES  16 B  291  LEU ASP ASN ARG ALA ILE ASP THR ALA GLN ILE GLN PRO
SEQRES  17 B  291  TYR ASP GLY HIS VAL THR LEU TYR MET ALA ASP ARG TYR
SEQRES  18 B  291  HIS ASP ASP ALA ILE MET PHE GLU PRO ARG TYR ALA VAL
SEQRES  19 B  291  ARG GLN PRO ASP GLY GLY TRP GLY GLU TYR VAL SER ASP
SEQRES  20 B  291  LEU GLU VAL VAL PRO ILE GLY GLY GLU HIS ILE GLN ALA
SEQRES  21 B  291  ILE ASP GLU PRO ILE ILE ALA LYS VAL GLY GLU HIS MET
SEQRES  22 B  291  SER ARG ALA LEU GLY GLN ILE GLU ALA ASP ARG THR SER
SEQRES  23 B  291  GLU VAL GLY LYS GLN
HET    7IJ  A1801      27
HET    7IJ  B1801      27
HETNAM     7IJ 3,8-BIS(OXIDANYL)-7-(PIPERIDIN-1-YLMETHYL)-
HETNAM   2 7IJ  [1]BENZOFURO[3,2-C]CHROMEN-6-ONE
FORMUL   3  7IJ    2(C21 H19 N O5)
FORMUL   5  HOH   *196(H2 O)
HELIX    1 AA1 SER A 1480  VAL A 1483  5                                   4
HELIX    2 AA2 TYR A 1484  ARG A 1490  1                                   7
HELIX    3 AA3 SER A 1506  GLY A 1523  1                                  18
HELIX    4 AA4 SER A 1533  LEU A 1549  1                                  17
HELIX    5 AA5 THR A 1571  ASN A 1591  1                                  21
HELIX    6 AA6 PRO A 1598  LEU A 1605  5                                   8
HELIX    7 AA7 ASP A 1606  GLY A 1622  1                                  17
HELIX    8 AA8 PRO A 1626  ALA A 1646  1                                  21
HELIX    9 AA9 HIS A 1664  GLU A 1671  1                                   8
HELIX   10 AB1 PRO A 1672  VAL A 1676  5                                   5
HELIX   11 AB2 GLU A 1698  ALA A 1702  5                                   5
HELIX   12 AB3 PRO A 1706  THR A 1727  1                                  22
HELIX   13 AB4 SER B 1480  VAL B 1483  5                                   4
HELIX   14 AB5 TYR B 1484  ARG B 1490  1                                   7
HELIX   15 AB6 SER B 1506  GLY B 1523  1                                  18
HELIX   16 AB7 SER B 1533  LEU B 1549  1                                  17
HELIX   17 AB8 THR B 1571  ASN B 1591  1                                  21
HELIX   18 AB9 PRO B 1598  LEU B 1602  5                                   5
HELIX   19 AC1 ASP B 1606  SER B 1619  1                                  14
HELIX   20 AC2 PRO B 1626  THR B 1645  1                                  20
HELIX   21 AC3 HIS B 1664  GLU B 1671  1                                   8
HELIX   22 AC4 PRO B 1672  VAL B 1676  5                                   5
HELIX   23 AC5 ILE B 1700  ASP B 1704  5                                   5
HELIX   24 AC6 PRO B 1706  THR B 1727  1                                  22
SHEET    1 AA1 8 GLN A1451  ASP A1453  0
SHEET    2 AA1 8 VAL A1456  ARG A1460 -1  O  THR A1458   N  GLN A1451
SHEET    3 AA1 8 MET A1497  PHE A1500 -1  O  GLY A1499   N  ARG A1457
SHEET    4 AA1 8 VAL A1471  PHE A1474  1  N  VAL A1473   O  PHE A1500
SHEET    5 AA1 8 TYR A1527  TRP A1532  1  O  VAL A1530   N  PHE A1472
SHEET    6 AA1 8 VAL A1553  ILE A1559  1  O  GLY A1557   N  LEU A1529
SHEET    7 AA1 8 TYR A1651  MET A1659  1  O  THR A1656   N  LEU A1558
SHEET    8 AA1 8 VAL A1687  PRO A1694  1  O  GLU A1691   N  LEU A1657
SHEET    1 AA2 8 ILE B1452  ASP B1453  0
SHEET    2 AA2 8 VAL B1456  ARG B1460 -1  O  VAL B1456   N  ASP B1453
SHEET    3 AA2 8 MET B1497  PHE B1500 -1  O  GLY B1499   N  ARG B1457
SHEET    4 AA2 8 VAL B1471  PHE B1474  1  N  VAL B1473   O  PHE B1500
SHEET    5 AA2 8 TYR B1527  TRP B1532  1  O  VAL B1530   N  PHE B1472
SHEET    6 AA2 8 VAL B1553  ILE B1559  1  O  ILE B1559   N  GLY B1531
SHEET    7 AA2 8 TYR B1651  MET B1659  1  O  TYR B1658   N  LEU B1558
SHEET    8 AA2 8 VAL B1687  PRO B1694  1  O  GLU B1691   N  LEU B1657
CISPEP   1 GLY A 1525    PRO A 1526          0        -0.90
CISPEP   2 GLU A 1705    PRO A 1706          0         0.53
CISPEP   3 GLY B 1525    PRO B 1526          0         0.36
CISPEP   4 GLU B 1705    PRO B 1706          0        -1.09
CRYST1   86.900   38.430  161.078  90.00 101.06  90.00 I 1 2 1       8
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.011508  0.000000  0.002248        0.00000
SCALE2      0.000000  0.026021  0.000000        0.00000
SCALE3      0.000000  0.000000  0.006326        0.00000
TER    2151      THR A1727
TER    4266      THR B1727
MASTER      299    0    2   24   16    0    0    6 4514    2   54   46
END